Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Association of PPARG rs 1801282 C>G polymorphism with risk of colorectal cancer: from a case-control study to a meta-analysis.

Jiang J, Xie Z, Guo J, Wang Y, Liu C, Zhang S, Tang W, Chen Y.

Oncotarget. 2017 Aug 10;8(59):100558-100569. doi: 10.18632/oncotarget.20138. eCollection 2017 Nov 21.

2.

Genetic Variants in the Insulin-like Growth Factor Pathway and Colorectal Cancer Risk in the Netherlands Cohort Study.

Simons CC, Schouten LJ, Godschalk RW, van Engeland M, van den Brandt PA, van Schooten FJ, Weijenberg MP.

Sci Rep. 2015 Sep 18;5:14126. doi: 10.1038/srep14126.

3.

Peroxisome proliferator-activated receptor-γ (PPARγ) Pro12Ala polymorphism and colorectal cancer (CRC) risk.

Wang W, Shao Y, Tang S, Cheng X, Lian H, Qin C.

Int J Clin Exp Med. 2015 Mar 15;8(3):4066-72. eCollection 2015.

4.

Effect of Proliferator-Activated Receptor-γ Pro12Ala Polymorphism on Colorectal Cancer Risk: A Meta-Analysis.

Wei Z, Han G, Bai X.

Med Sci Monit. 2015 Jun 2;21:1611-6. doi: 10.12659/MSM.892849.

5.

Association between six genetic polymorphisms and colorectal cancer: a meta-analysis.

Chen C, Wang L, Liao Q, Xu L, Huang Y, Zhang C, Ye H, Xu X, Ye M, Duan S.

Genet Test Mol Biomarkers. 2014 Mar;18(3):187-95. doi: 10.1089/gtmb.2013.0425. Epub 2014 Feb 19.

6.

Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk.

Wang H, Taverna D, Stram DO, Fortini BK, Cheng I, Wilkens LR, Burnett T, Makar KW, Lindor NM, Hopper JL, Gallinger S, Baron JA, Haile R, Kolonel LN, Henderson BE, Newcomb PA, Casey G, Duggan D, Ulrich CM, Le Marchand L.

Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2094-101. doi: 10.1158/1055-9965.EPI-13-0694. Epub 2013 Sep 17.

7.

The Role of PPARγ in Helicobacter pylori Infection and Gastric Carcinogenesis.

Lee JM, Kim SS, Cho YS.

PPAR Res. 2012;2012:687570. doi: 10.1155/2012/687570. Epub 2012 Aug 9.

8.

The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course.

Mwinyi J, Grete-Wenger C, Eloranta JJ, Kullak-Ublick GA.

PPAR Res. 2012;2012:349469. doi: 10.1155/2012/349469. Epub 2012 Feb 14.

9.

Genetic variation in peroxisome proliferator-activated receptor gamma, soy, and mammographic density in Singapore Chinese women.

Lee E, Hsu C, Van den Berg D, Ursin G, Koh WP, Yuan JM, Stram DO, Yu MC, Wu AH.

Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):635-44. doi: 10.1158/1055-9965.EPI-11-1042. Epub 2012 Feb 1.

10.

Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer.

Crous-Bou M, Rennert G, Salazar R, Rodriguez-Moranta F, Rennert HS, Lejbkowicz F, Kopelovich L, Lipkin SM, Gruber SB, Moreno V.

Mutagenesis. 2012 Mar;27(2):169-76. doi: 10.1093/mutage/ger066.

11.

Peroxisome proliferator-activated receptor-gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis.

Lu YL, Li GL, Huang HL, Zhong J, Dai LC.

World J Gastroenterol. 2010 May 7;16(17):2170-5.

Supplemental Content

Support Center